Chengdu Kanghong Pharmaceutical Group Valuation

Q: What is the Fair Price of 2773 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

002773 (CN¥22.56) is trading below our estimate of [[fair value]] (CN¥79.92)

Is 2773 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 2773 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 002773 (CN¥22.56) is trading below our estimate of fair value (CN¥79.92)

Significantly Below Fair Value: 002773 is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 2773?

Other financial metrics that can be useful for relative valuation.

The above table shows the n/a ratio for 2773. This is calculated by dividing 2773's market cap by their current preferred multiple.
What is 2773's n/a Ratio?
n/a	0x
n/a	n/a
Market Cap	CN¥20.74b

2773 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	3.8x
Enterprise Value/EBITDA	10.9x
PEG Ratio	1.2x

Price to Earnings Ratio vs Peers

How does 2773's PE Ratio compare to its peers?

The above table shows the PE ratio for 2773 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	18x
600380 Joincare Pharmaceutical Group IndustryLtd	16.9x	12.3%	CN¥24.0b
600535 Tasly Pharmaceutical Group	20.5x	11.9%	CN¥22.6b
600062 China Resources Double-Crane PharmaceuticalLtd	17.2x	11.1%	CN¥23.6b
600867 Tonghua Dongbao Pharmaceutical	17.5x	12.2%	CN¥19.8b
002773 Chengdu Kanghong Pharmaceutical Group	18.2x	14.7%	CN¥20.7b

Price-To-Earnings vs Peers: 002773 is expensive based on its Price-To-Earnings Ratio (18.2x) compared to the peer average (18x).

Price to Earnings Ratio vs Industry

How does 2773's PE Ratio compare vs other companies in the CN Pharmaceuticals Industry?

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	19.2%
	n/a	n/a	n/a

Fetching data

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	19.2%
	n/a	n/a	n/a

No more companies

Price-To-Earnings vs Industry: 002773 is good value based on its Price-To-Earnings Ratio (18.2x) compared to the CN Pharmaceuticals industry average (30.9x).

Price to Earnings Ratio vs Fair Ratio

What is 2773's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

2773 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	18.2x
Fair PE Ratio	26.8x

Price-To-Earnings vs Fair Ratio: 002773 is good value based on its Price-To-Earnings Ratio (18.2x) compared to the estimated Fair Price-To-Earnings Ratio (26.8x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.